A 52-year-old man was admitted to our hospital for diabetic ketoacidosis. On admission, HbAic was 6.5%, anti-GAD antibody 10.3 U/ml, serum amylase 144 IU//, lipase 169 XJ/l and elastase-1 1,000 ng/dl. There were no abdominal symptoms, and abdominal CT showed unremarkable findings. He was treated with intensive insulin therapy. After 1 month, urinary excretion of C-peptide was 3.8 jig/day. Serum pancreatic exocrine enzyme concentrations returned to normal after 3 months. After 10 months, anti-GAD antibody had become negative, but insulin therapy was still needed for glycemic control. This report concerns a case of autoimmunefulminating onset type 1 diabetes. (Internal Medicine 42: 517-520, 2003) 
Introduction
According to the American Diabetes Association Expert Committee 1997 guidelines, type 1 diabetes mellitus can be classified into immune-mediated diabetes (type 1A) and idiopathic diabetes (type IB) (1). While the former is characterized by the presence of islet-related autoantibodies such as anti glutamic acid decarboxylase (GAD) antibody and IA-2 antibody, the latter lacks immunological evidence of beta cell autoimmunity. The rate of beta cell destruction in type 1A diabetes is generally slow in adult patients (2, 3), and the levels of anti-GAD antibody in type 1A diabetic patients are persistently positive for a long time (4). Some forms of type IB diabetes have no knownetiology, and these patients are prone to have diabetes combined with ketoacidosis frequently. Recently, Imagawaet al reported that somepatients with type IB diabetes were characterized by a remarkable abrupt onset, the absence of islet-related autoantibodies and high levels of serum pancreatic enzyme concentrations (5). This subtype is called nonautoimmune "fulminant type 1 diabetes." However, the precise mechanism of beta cell destruction and the significance of the elevated serum pancreatic exocrine enzyme concentrations in this subtype of diabetes remain unclear. Here, we report a case of fulminant type 1-like diabetes with transient anti-GAD antibody positivity.
Case Report
A 52-year-old Japanese man, who had been in good health and drank little, had been suffering from thirst since November 30, 2001. General malaise and poor appetite developed gradually, and he was admitted to a local hospital on December 9. Laboratory data on admission were as follows: white blood cell count of 6,100/jul, hemoglobin of 15.4 g/dl, platelet count of 28.9xlO7|ul, total bilirubin of 0. protein of 0.7 mg/dl, plasma glucose of 629 mg/dl and ketone body of more than 1,500 jumol//. Laboratory data showed hyperglycemia and ketosis, and he was treated with subcutaneous insulin infusion therapy. However, his blood glucose level remained high, and he was referred to our hospital on December 14. He was 164 cm tall and weighed 58 kg. Vital signs were body temperature of 36.9°C, blood pressure of 126/87 mmHg,and regular pulse of 1 19/min. Other physical examinations yielded no remarkable findings. Laboratory data on transfer to our hospital are summarized in Table 1 , and showed 6.5% for HbAic, 10.3 U/ml for anti-GAD antibody ("Cosmic", Tokyo, Japan; normal range: less than 1.4 U/ml), mmol// and base excess 2.7 mmol//, while the blood glucose level had decreased to 261 mg/dl. The patient was prescribed a 1,600 kcal/day diet followed by intensive insulin therapy.
Nevertheless, his blood glucose levels remained unstable (Fig. 1) . In January 2002, his urinary excretion of C-peptide was as low as 3.8 jug/day, anti-GAD antibody remained posi- 
Discussion
Type 1 diabetes mellitus is caused by loss of insulin secreting capacity due to selective destruction of the pancreatic beta cells, and insulitis is the direct result of the autoimmune process. GAD is regarded to be the primary antigen for autoimmunity toward pancreatic beta cells (6), and antiGADantibody has definitively been proven to be a sensitive marker for diagnosis of type 1 diabetes (7) . However, about 17%of the patients with type 1 diabetes do not have any islet-related antibodies (8 Recently, Sakurai and Nishimura reported that a case of acute pancreatitis developed into type 1 diabetes (9) . Their case was characterized by 1) a low HbAic level; 2) low titers for viral antibodies and no detectable islet-related autoantibodies; and 3) elevated pancreatic exocrine enzyme concentrations with diffuse pancreatic swelling seen on abdominal CT. This type IB diabetes case had sustained the high levels of serum pancreatic exocrine enzymes for 6 months, and the continuation of active pancreatic inflammation may have triggered simultaneous beta cell destruction.
However, type 1 diabetes can not be induced only by elevated serum pancreatic exocrine enzymeconcentrations, because acute pancreatitis does not usually develop into diabetes. The mechanisms of disease development in these cases with a remarkable abrupt onset, absence of islet-related autoantibodies and high levels of serum pancreatic enzyme concentrations remain unclear.
On the other hand, Shimada et al reported that a case of "fulminant type 1 diabetes" showed high levels of serum interferon-inducible protein 10 (IP-10) and GAD-reactive interferon-gamma-producing CD4+cells, and suggested that T cell-mediated autoimmunity might be involved (10). Tanaka et al also reported that a case of "fulminant type 1 diabetes" showed CD8T-cell-dominant insulitis on histopathological examination of the pancreas (ll) . Another study found an association of hyperlipasemia at clinical onset of insulindependent diabetes with a high titer of islet cell cytoplasmic autoantibodies (12) . In addition, another case report stated that anti-GAD antibody level showed a gradual increase during the course of the disease diagnosed as "fulminant type 1 diabetes" (13) . The mechanism resulting in "fulminant type 1 diabetes" with no detectable islet-related autoantibodies at clinical onset maythus be associated to some extent with autoimmunity.
In the present case, HLAtype was A26, All, B39, B61, CW7, CW8in class I antigen, and DR8, DR9, DQ1, DQ3 
